Back to today’s briefing

Story perspectives

2.2 Million Americans Urgently Need HIV Prevention Efforts

6/25/2025

48 5

Summary

Public Health Urgency

A groundbreaking study in the Annals of Epidemiology reveals that over 2.2 million Americans are in urgent need of pre-exposure prophylaxis (PrEP) to fight HIV, particularly among high-risk populations. This vital information empowers public health officials to allocate resources effectively and strive towards the ambitious goal of slashing HIV infections by 90%.

Summary

FDA Approves Yeztugo

The FDA has greenlit lenacapavir, known as Yeztugo, a groundbreaking twice-yearly injection for HIV prevention. Clinical trials revealed it nearly eradicated new infections in high-risk groups, providing a promising alternative to daily pills. Yet, pressing issues of affordability and accessibility loom large, threatening its potential impact on public health.

1 of 2

Public Health Urgency

A groundbreaking study in the Annals of Epidemiology reveals that over 2.2 million Americans are in urgent need of pre-exposure prophylaxis (PrEP) to fight HIV, particularly among high-risk populations. This vital information empowers public health officials to allocate resources effectively and strive towards the ambitious goal of slashing HIV infections by 90%.

1 / 2